Alnylam Pharmaceuticals
ALNY
#496
Rank
NZ$84.59 B
Marketcap
NZ$640.33
Share price
-0.61%
Change (1 day)
38.95%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company